chakraborty appi mumbai 140615

29
Monoclonal Protein Interferences in Clinical Chemistry Dr Sutirtha Chakraborty, MD (Biochemistry), FACB (USA) Chief Consultant , Dept. of Biochemistry Peerless Hospital, Kolkata 1

Upload: drsutirtha-chakrabortymdfacb

Post on 19-Feb-2017

410 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Chakraborty APPI Mumbai 140615

Monoclonal Protein Interferences in Clinical Chemistry

Dr Sutirtha Chakraborty,

MD (Biochemistry), FACB (USA)

Chief Consultant , Dept. of Biochemistry

Peerless Hospital, Kolkata 1

Page 2: Chakraborty APPI Mumbai 140615

CASE STUDY

• 58 year old male , known hypertensive on treatment.

• Presents to hospital with progressive fatigue & weakness for the past 2 months.

• Patient also complained of shortness of breath for the past 2 weeks.

• Hb 9.5 gm/dL( RI: 12 – 15)

• Normocytic, Normochromic type

• WBC count(total & differential) –Normal2

Page 3: Chakraborty APPI Mumbai 140615

• Creatinine 2.05 mg/dl (RI 0.6 – 1.2 mg/dl)

• Urine Albumin(dipstick): Trace

• Serum Sodium 137 mmol/L (RI: 135-145)

• Serum Potassium 3.9 mmol/L (3.5 – 5.3)

Nephrologist Consult:Serum Calcium, Phosphate and Uric Acid

Case Study 1…….Contd.

3

Page 4: Chakraborty APPI Mumbai 140615

• Serum Calcium : 10 mg/dL (RI: 8.5 – 10.5)

• Serum Uric Acid: 9.0 mg/dL (RI: 3.5 – 7.0)

• Serum Phosphate: 28.4 mg/dl (RI: 2.5 – 4.5)

• Plasma PTH: 22 pg/mL (RI: 15 – 65)

•What could be the cause of extreme hyperphosphatemia in this patient?

4

Page 5: Chakraborty APPI Mumbai 140615

Spurious Lab Results

• Significant number of laboratory results andreports are factitious or misinterpreted.

• Such laboratory results often lead tounnecessary testing or treatment.

• An observant Laboratory Physician shouldidentify, intervene & investigate the error.

• Spurious/ Factitious results most commonlyoccour due to assay Interference in the“Analytical Phase”

• Major cause of reputational risk for labs.5

Page 6: Chakraborty APPI Mumbai 140615

Monoclonal Gammopathy

• Expansion of a single Ig-secreting plasma cell population.

• Most cases involve IgG or IgA monoclonal cell populations. About 15-20% are composed of IgMmonoclonal cells.

• Disorders associated with Monoclonal Protein:

MGUS, Multiple Myeloma (MM), Waldenströmmacroglobulinemia (WM), amyloidosis (AL) or other lymphoproliferative disorders.

6

Page 7: Chakraborty APPI Mumbai 140615

Ig G-Kappa mediated Spurious Hyperphosphatemia

• Loss of linearity

• ? Monoclonal Protein

• Serum Total Protein: 8.1 g/dL, Albumin 3.5 g/dL• Serum Protein Electrophoresis : Sharp Band of restricted mobility in Gamma region

Immunofixation:Positive for Ig G - Kappa

7

Page 8: Chakraborty APPI Mumbai 140615

8

Page 9: Chakraborty APPI Mumbai 140615

Interference as a result of Ig G – Kappa monoclonal protein

1 2 3

Image: from Dr Graham Jones, Australia9

Page 10: Chakraborty APPI Mumbai 140615

Pseudohyperphosphatemia

• The frequency of immunoglobulin-inducedlaboratory errors is variable and probablyunderreported.

• up to 1 in 4 patients with monoclonalgammopathy show interference in PO4 assay.

• Pseudohypophosphatemia can also be seenas a result of such interference.

• Various “wet chemistry” phosphomolybdateassay is vulnerable to this interference.

10

Page 11: Chakraborty APPI Mumbai 140615

Spurious Hyperbilirubinemia

• Monoclonal protein interferences occur withtotal bilirubin measurements leading to falsehigh results.

• Results typically show T Bil > 15 mg/dL withcorresponding increased Indirect Bilirubin asresult of normal direct Bil.

• Apparently results mimic Hemolytic anemia.

• Common Culprit: Ig G-Lambda , Ig M (in WM)

11

Page 12: Chakraborty APPI Mumbai 140615

Pantanwitz et al. Arch of Pathology 200412

Page 13: Chakraborty APPI Mumbai 140615

Ig M interference with HDL Cholesterol Assay

Female, 58 years

Diagnosed with WM

Total C : 202 mg/dL

HDL C: 11 mg/dL

LDL C : 139 mg/dL

TG: 165 mg/dL

VLDL : 52 mg/dL

13

Page 14: Chakraborty APPI Mumbai 140615

Spuriously Elevated CRP

• CRP > 300 mg/L

• Procalcitonin : 0.07 ng/mL

• Full Blood Counts: Normal

• Blood Cultures: - Ve

• Final Diagnosis:

Light chain myeloma

14

Page 15: Chakraborty APPI Mumbai 140615

Hypercalcemia & Myeloma

• Ig A Myeloma

• Extensive bone lytic lesions.

• BM Plasma Cells 30 %

• SPE : M band ( 4.8 g/dL)

• Serum Calcium 19.3 mg/dL

(Arsenazo Method)

To treat or not to treat this hypercalcemia ?????????

15

Page 16: Chakraborty APPI Mumbai 140615

Monoclonal Protein InterferencesDalal et al. AJCP 2009

16

Page 17: Chakraborty APPI Mumbai 140615

Strategies: What to do?

• Check the serum colour to see if it is truly icteric.

• Spectrophotometric measurement using an Iindex, if available on the autoanalyzer. (LIHindex)

• Rerun the assay to demonstrate any imprecisionbeyond what is typically observed.

• Check for loss of linearity (Serial dilutions)

• Measure the analyte using a different method.

• Always Correlate result with the clinicalinformation.

17

Page 18: Chakraborty APPI Mumbai 140615

Multi-layer Thin Film Dry Slide Technology

18

Page 19: Chakraborty APPI Mumbai 140615

Simple techniques for removing Monoclonal Protein Interferences

1) Salting Out Methods2) Precipitation with TCA3) Ultrafiltration4) Dialysis5) Polyethylene Glycol (PEG)

Caution: Make sure that the analyte of interest is insensitive to this procedure. (Works well with Phosphate, Uric Acid, Bilirubin but not with CRP, HDL-C)

19

Page 20: Chakraborty APPI Mumbai 140615

20

Page 21: Chakraborty APPI Mumbai 140615

Pseudohyponatremia

• Caused by displacementof serum water byelevated concentrationsof serum lipids orproteins.

• Indirect ISE involvessample dilution and willproduce spuriously lowsodium.

• Occurs when TP > 12g/dL

Fortgens P, Archives of Path & Lab Med ,201121

Page 22: Chakraborty APPI Mumbai 140615

Monoclonal protein interference in the Preanalytical Phase

Chakraborty et al. CCLM 2014 22

Page 23: Chakraborty APPI Mumbai 140615

23

Page 24: Chakraborty APPI Mumbai 140615

Which reagent do you choose ?

• Total Protein Regent 1

• Method: Biuret

• CV% - 1.8 %

• EQAS Outliers - None

• Pack Size – Same

• CPT: Rs 5/test

• Total Protein Regent 2

• Method: Biuret

• CV% - 1.9%

• EQAS Outliers - None

• Pack Size – Same

• CPT: Rs 1.25/test

24

Page 25: Chakraborty APPI Mumbai 140615

Case Study

• A 50-year-old woman was being treated for sudden-onset sensorineural deafness.

• LFT showed Total protein 10.1 g/dL and albumin was 3.5 g/dL.

• Results Rechecked and released with a comment “Marked A:G ratio reversal noted advised Serum Protein Electrophoresis”

• Subsequent tests requested : SPE, IF, Sr. Calcium

25Chakraborty , Clin Chem 2015

Page 26: Chakraborty APPI Mumbai 140615

• Normal Electrophoreticpattern with IF negative.

• Dextran is used in the management of sudden hearing loss.

• Dextran Interference on Biuret Assay?????

• So which reagent do we choose?

26

Page 27: Chakraborty APPI Mumbai 140615

JCLA, DECEMBER 2014

Conclusion:

“The results show that it is possible to use analytical interference for diagnostic purposes, and most importantly, almost all cases were identified at an early stage of the disease, when associated clinical manifestations were not yet observed”.

27

Page 28: Chakraborty APPI Mumbai 140615

Key Learning Points• Since systemic deproteinisation of serum is no longer applied

in modern assays, interferences caused by monoclonal proteins will continue to occur.

• All chemistry assays in patients with known monoclonal gammopathies should be reviewed.

• Always check Manufacturer Kit Insert for possible interferences.

Awareness is the key!

28

Page 29: Chakraborty APPI Mumbai 140615

Thank You

29